BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1342132)

  • 1. Fulminant Labrea hepatitis--the role of hepatitis A (HAV), B (HBV), C (HCV), and D (HDV) infection. (Preliminary report).
    da Fonseca JC; Ferreira LC; Brasil LM; Castilho Mda C; Moss R; Barone M
    Rev Inst Med Trop Sao Paulo; 1992; 34(6):609-12. PubMed ID: 1342132
    [No Abstract]   [Full Text] [Related]  

  • 2. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections.
    Mathurin P; Thibault V; Kadidja K; Ganne-Carrié N; Moussalli J; El Younsi M; Di Martino V; Lunel F; Charlotte F; Vidaud M; Opolon P; Poynard T
    J Viral Hepat; 2000 Jan; 7(1):15-22. PubMed ID: 10718938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review.
    Dakurah OB; Tamandjou CRT; Zunza M; Preiser W; Maponga TG
    BMC Cancer; 2021 Jun; 21(1):715. PubMed ID: 34144696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant hepatitis with microvesicular steatosis (a histologic comparison of cases occurring in Brazil--Labrea hepatitis--and in central Africa--Bangui hepatitis).
    Andrade ZA; Lesbordes JL; Ravisse P; Paraná R; Prata A; Barberino JS; Trepo C
    Rev Soc Bras Med Trop; 1992; 25(3):155-60. PubMed ID: 1308946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.
    Krajden S; Bishai F; Huang SN; Ronald A; Harris F; Kempston J; Anderson J; Keston S
    CMAJ; 1986 Dec; 135(11):1282-5. PubMed ID: 3536053
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical features of hepatitis D.
    Farci P; Niro GA
    Semin Liver Dis; 2012 Aug; 32(3):228-36. PubMed ID: 22932971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR; Oliveri F; Colombatto P; Bonino F
    Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant liver failure from acute HCV superinfection in a patient with HIV, HBV, and HDV coinfections.
    Lee K; Smith PT
    AIDS Read; 2000 Jul; 10(7):398, 401. PubMed ID: 10932838
    [No Abstract]   [Full Text] [Related]  

  • 10. Fulminant viral hepatitis.
    Fagan EA; Williams R
    Br Med Bull; 1990 Apr; 46(2):462-80. PubMed ID: 2116214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis in multiple virus infection: histopathological evaluation.
    Colombari R; Dhillon AP; Piazzola E; Tomezzoli AA; Angelini GP; Capra F; Tomba A; Scheuer PJ
    Histopathology; 1993 Apr; 22(4):319-25. PubMed ID: 8514275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of triple infection with hepatitis B, C and D viruses.
    Riaz M; Idrees M; Kanwal H; Kabir F
    Virol J; 2011 Jul; 8():368. PubMed ID: 21791115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological and histological re-evaluation of Labrea hepatitis.
    Paraná R; Andrade Z; de Freitas LA; Prata A; Kay A; Santos JB
    Acta Gastroenterol Latinoam; 2008 Dec; 38(4):284-90. PubMed ID: 19157384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis A, B, C and D. Pathological anatomy].
    Voigt JJ; Degott C
    Rev Prat; 1993 Sep; 43(14):1857-8. PubMed ID: 8310233
    [No Abstract]   [Full Text] [Related]  

  • 16. Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., Germany.
    Weber B; Rabenau H; Berger A; Scheuermann EH; Staszewski S; Kreuz W; Scharrer I; Schoeppe W; Doerr HW
    Zentralbl Bakteriol; 1995 Jan; 282(1):102-12. PubMed ID: 7734823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hepatitis.
    Yasmin AM
    Med J Malaysia; 1997 Jun; 52(2):188-92; quiz 193. PubMed ID: 10968083
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections?
    Buti M; Jardi R; Allende H; Cotrina M; Rodriguez F; Viladomiu L; Esteban R; Guardia J
    J Med Virol; 1996 May; 49(1):66-9. PubMed ID: 8732862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers.
    Sansonno DE; Fiore G; Pietropaolo F; Avellis D; Napoli N; Manghisi OG
    Digestion; 1988; 39(4):197-203. PubMed ID: 3146516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.